Focal chromosomal copy number aberrations in cancer-Needles in a genome haystack

Biochimica et Biophysica Acta - Molecular Cell Research

Volumn 1843, Issue 11, 2014, Pages 2698-2704

  Krijgsman, Oscar ^a   Carvalho, Beatriz ^a   Meijer, Gerrit A ^a   Steenbergen, Renske D M ^a   Ylstra, Bauke ^a  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Chromosomal aberrations; Driver genes; Focal CNA; Oncogenes; Tumor suppressor genes

Indexed keywords

BIOINFORMATICS; BREAST CANCER; CANCER CELL; CHROMOSOMAL COPY NUMBER ABERRATION; CHROMOSOME; CHROMOSOME ABERRATION; COLORECTAL CARCINOMA; COMPARATIVE GENOMIC HYBRIDIZATION; COPY NUMBER VARIATION; DIGESTIVE SYSTEM CANCER; ESOPHAGEAL CANCER CELL LINE; GENE DOSAGE; GLIOBLASTOMA; HEAD AND NECK SQUAMOUS CELL CARCINOMA; HUMAN; HUMAN GENOME; LUNG CANCER; LUNG NON SMALL CELL CANCER; LYMPHOMA; MALIGNANT NEOPLASTIC DISEASE; MUTATIONAL ANALYSIS; PRIORITY JOURNAL; PROSTATE CANCER; REVIEW; SINGLE NUCLEOTIDE POLYMORPHISM; TUMOR GENE; TUMOR SUPPRESSOR GENE; UTERINE CERVIX CARCINOMA;

EID: 84905962250     PISSN: 01674889     EISSN: 18792596     Source Type: Journal    
DOI: 10.1016/j.bbamcr.2014.08.001     Document Type: Review

References (65)

1. MacDonald J.R., Ziman R., Yuen R.K.C., Feuk L., Scherer S.W. The database of genomic variants: a curated collection of structural variation in the human genome. Nucleic Acids Res. 2014, 42:D986-D992.
2. Santarius T., Shipley J., Brewer D., Stratton M.R., Cooper C.S. A census of amplified and overexpressed human cancer genes. Nat. Rev. Cancer 2010, 10:59-64.
3. Davoli T., Xu A.W., Mengwasser K.E., Sack L.M., Yoon J.C., Park P.J., et al. Cumulative haploinsufficiency and triplosensitivity drive aneuploidy patterns and shape the cancer genome. Cell 2013, 155:948-962.
4. Tjio J.H., Levan A. The chromosome number of man. Hereditas 2010, 42:1-6.
5. Watson J.D., Crick F. Molecular structure of nucleic acids: A Structure for Deoxyribose Nucleic Acid. Nature 1953, 171:737-738.
6. Hardy P.A., Zacharias H. Reappraisal of the Hansemann-Boveri hypothesis on the origin of tumors. Cell Biol. Int. 2005, 12:983-992.
7. Rowley J.D. A new consistent chromosomal abnormality in chronic myelogenous leukaemia identified by quinacrine fluorescence and giemsa staining. Nature 1973, 243:290-293.
8. Nowell P.C., Hungerford D.A. Chromosome studies on normal and leukemic human leukocytes. J. Natl. Cancer Inst. 1960, 25:85-109.
9. Van Prooijen-Knegt A.C., Van Hoek J.F.M., Bauman J.G.J., Van Duijn P., Wool I.G., Van der Ploeg M. In situ hybridization of DNA sequences in human metaphase chromosomes visualized by an indirect fluorescent immunocytochemical procedure. Exp. Cell Res. 1982, 141:397-407.
10. Barker P.E. Double minutes in human tumor cells. Cancer Genet. Cytogenet. 1982, 5:81-94.
11. Biedler J.L., Spengler B.A. Metaphase chromosome anomaly: association with drug resistance and cell-specific products. Science 1976, 191:185-187.
12. Solinas-Toldo S., Lampel S., Stilgenbauer S., Nickolenko J., Benner A., Döhner H., et al. Matrix-based comparative genomic hybridization: biochips to screen for genomic imbalances. Genes Chromosom. Cancer 1997, 20:399-407.
13. Manoir S., Speicher M., Joos S., Schröck E., Popp S., Döhner H., et al. Detection of complete and partial chromosome gains and losses by comparative genomic in situ hybridization. Hum. Genet. 1993, 90:590-610.
14. Kallioniemi A., Kallioniemi O.P., Sudar D., Rutovitz D., Gray J.W., Waldman F., et al. Comparative genomic hybridization for molecular cytogenetic analysis of solid tumors. Science 1992, 258:818-821.
15. Brown P.O., Pollack J.R., Perou C.M., Alizadeh A.A., Eisen M.B., Pergamenschikov A., et al. Genome-wide analysis of DNA copy-number changes using cDNA microarrays. Nat. Genet. 1999, 23:41-46.
16. Snijders A.M., Nowak N., Segraves R., Blackwood S., Brown N., Conroy J., et al. Assembly of microarrays for genome-wide measurement of DNA copy number. Nat. Genet. 2001, 29:263-264.
17. Pinkel D., Segraves R., Sudar D., Clark S., Poole I., Kowbel D., et al. High resolution analysis of DNA copy number variation using comparative genomic hybridization to microarrays. Nat. Genet. 1998, 20:207-211.
18. Bignell G.R. High-resolution analysis of DNA copy number using oligonucleotide microarrays. Genome Res. 2004, 14:287-295.
19. Bentz M., Plesch A., Stilgenbauer S., Döhner H., Lichter P. Minimal sizes of deletions detected by comparative genomic hybridization. Genes Chromosom. Cancer 1998, 21:172-175.
20. Ylstra B., van den Ijssel P., Carvalho B., Brakenhoff R.H., Meijer G.A. BAC to the future! or oligonucleotides: a perspective for micro array comparative genomic hybridization (array CGH). Nucleic Acids Res. 2006, 34:445-450.
21. Pinto D., Darvishi K., Shi X., Rajan D., Rigler D., Fitzgerald T., et al. Comprehensive assessment of array-based platforms and calling algorithms for detection of copy number variants. Nat. Biotechnol. 2011, 29:512-520.
22. Iafrate A.J., Feuk L., Rivera M.N., Listewnik M.L., Donahoe P.K., Qi Y., et al. Detection of large-scale variation in the human genome. Nat. Genet. 2004, 36:949-951.
23. Sharp A.J., Locke D.P., McGrath S.D., Cheng Z., Bailey J.A., Vallente R.U., et al. Segmental duplications and copy-number variation in the human genome. Am. J. Hum. Genet. 2005, 77:78-88.
24. Feuk L., Carson A.R., Scherer S.W. Structural variation in the human genome. Nat. Rev. Genet. 2006, 7:85-97.
25. Garnis C., Lockwood W.W., Vucic E., Ge Y., Girard L., Minna J.D., et al. High resolution analysis of non-small cell lung cancer cell lines by whole genome tiling path array CGH. Int. J. Cancer 2005, 118:1556-1564.
26. Weir B.A., Woo M.S., Getz G., Perner S., Ding L., Beroukhim R., et al. Characterizing the cancer genome in lung adenocarcinoma. Nature 2007, 450:893-898.
27. Mermel C.H., Schumacher S.E., Hill B., Meyerson M.L., Beroukhim R., Getz G. GISTIC2.0 facilitates sensitive and confidentlocalization of the targets of focal somatic copy-number alteration in human cancers. Genome Biol. 2011, 12:R41.
28. Leary R.J., Lin J.C., Cummins J., Boca S., Wood L.D., Parsons D.W., et al. Integrated analysis of homozygous deletions, focal amplifications, and sequence alterations in breast and colorectal cancers. Proc. Natl. Acad. Sci. U. S. A. 2008, 105:16224-16229.
29. Wood H.M., Belvedere O., Conway C., Daly C., Chalkley R., Bickerdike M., et al. Using next-generation sequencing for high resolution multiplex analysis of copy number variation from nanogram quantities of DNA from formalin-fixed paraffin-embedded specimens. Nucleic Acids Res. 2010, 38:e151-e151.
30. Smeets S.J., Harjes U., van Wieringen W.N., Sie D., Brakenhoff R.H., Meijer G.A., et al. To DNA or not to DNA? That is the question, when it comes to molecular subtyping for the clinic!. Clin. Cancer Res. 2011, 17:4959-4964.
31. Chao H.H., He X., Parker J.S., Zhao W., Perou C.M. Micro-scale genomic DNA copy number aberrations as another means of mutagenesis in breast cancer. PLoS ONE 2012, 7:e51719.
32. Veeriah S., Taylor B.S., Meng S., Fang F., Yilmaz E., Vivanco I., et al. Somatic mutations of the Parkinson's disease-associated gene PARK2 in glioblastoma and other human malignancies. Nat. Genet. 2009, 42:77-82.
33. Bignell G.R., Greenman C.D., Davies H., Butler A.P. Signatures of mutation and selection in the cancer genome. Nature 2010, 463:893-898.
34. Bierkens M., Krijgsman O., Wilting S.M., Bosch L., Jaspers A., Meijer G.A., et al. Focal aberrations indicate EYA2and hsa-miR-375as oncogene and tumor suppressor in cervical carcinogenesis. Genes Chromosom. Cancer 2012, 52:56-68.
35. Beroukhim R., Getz G., Nghiemphu L., Barretina J., Hsueh T., Linhart D., et al. Assessing the significance of chromosomal aberrations in cancer: methodology and application to glioma. Proc. Natl. Acad. Sci. 2007, 104:20007-20012.
36. Beroukhim R., Mermel C.H., Porter D., Wei G., Raychaudhuri S., Donovan J., et al. The landscape of somatic copy-number alteration across human cancers. Nature 2010, 463:899-905.
37. McLendon R., Friedman A., Bigner D., Van Meir E.G., Brat D.J., Mastrogianakis G.M., et al. Comprehensive genomic characterization defines human glioblastoma genes and core pathways. Nature 2008, 455:1061-1068.
38. Dulak A.M., Schumacher S.E., van Lieshout J., Imamura Y., Fox C., Shim B., et al. Gastrointestinal adenocarcinomas of the esophagus, stomach, and colon exhibit distinct patterns of genome instability and oncogenesis. Cancer Res. 2012, 72:4383-4393.
39. Olshen A.B., Venkatraman E.S., Lucito R., Wigler M. Circular binary segmentation for the analysis of array-based DNA copy number data. Biostatistics 2004, 5:557-572.
40. van de Wiel M.A., Kim K.I., Vosse S.J., van Wieringen W.N., Wilting S.M., Ylstra B. CGHcall: calling aberrations for array CGH tumor profiles. Bioinformatics 2007, 23:892-894.
41. van de Wiel M.A., Picard F., van Wieringen W.N., Ylstra B. Preprocessing and downstream analysis of microarray DNA copy number profiles. Brief. Bioinform. 2011, 12:10-21.
42. Hur Y., Lee H. Wavelet-based identification of DNA focal genomic aberrations from single nucleotide polymorphism arrays. BMC Bioinforma. 2011, 12:146.
43. Brennan C.W., Verhaak R.G.W., McKenna A., Campos B., Noushmehr H., Salama S.R., et al. The somatic genomic landscape of glioblastoma. Cell 2013, 155:462-477.
44. Barrett T., Troup D.B., Wilhite S.E., Ledoux P., Evangelista C., Kim I.F., et al. NCBI GEO: archive for functional genomics data sets-10years on. Nucleic Acids Res. 2011, 39:D1005-D1010.
45. Rustici G., Kolesnikov N., Brandizi M., Burdett T., Dylag M., Emam I., et al. ArrayExpress update-trends in database growth and links to data analysis tools. Nucleic Acids Res. 2013, 41:D987-D990.
46. Costa J.L., Meijer G., Ylstra B., Caldas C. Array comparative genomic hybridization copy number profiling: a new tool for translational research in solid malignancies. Semin. Radiat. Oncol. 2008, 18:98-104.
47. Hanahan D., Weinberg R.A. Hallmarks of cancer: the next generation. Cell 2011, 144:646-674.
48. Brosens R.P., Haan J.C., Carvalho B., Rustenburg F., Grabsch H., Quirke P., et al. Candidate driver genes in focal chromosomal aberrations of stage II colon cancer. J. Pathol. 2010, 221:411-424.
49. Krijgsman O., Gonzalez P., Ponz O.B., Roemer M.G.M., Slot S., Broeks A., et al. Dissecting the gray zone between follicular lymphoma and marginal zone lymphoma using morphological and genetic features. Haematologica 2013, 98:1921-1929.
50. Day E., Poulogiannis G., McCaughan F., Mulholland S., Arends M.J., Ibrahim A.E., et al. IRS2 is a candidate driver oncogene on 13q34 in colorectal cancer. Int. J. Exp. Pathol. 2013, 94:203-211.
51. Varambally S., Cao Q., Mani R.S., Shankar S., Wang X., Ateeq B., et al. Genomic loss of microRNA-101 leads to overexpression of histone methyltransferase EZH2 in cancer. Science 2008, 322:1695-1699.
52. Mitsui J., Takahashi Y., Goto J., Tomiyama H., Ishikawa S., Yoshino H., et al. Mechanisms of genomic instabilities underlying two common fragile-site-associated loci, PARK2 and DMD, in germ cell and cancer cell lines. Am. J. Hum. Genet. 2010, 87:75-89.
53. Hudis C.A. Trastuzumab-mechanism of action and use in clinical practice. N. Engl. J. Med. 2007, 357:39-51.
54. Schmidt M.L. Favorable prognosis for patients 12 to 18 months of age with stage 4 nonamplified MYCN neuroblastoma: a Children's Cancer Group Study. J. Clin. Oncol. 2005, 23:6474-6480.
55. Morris L.G., Taylor B.S., Bivona T.G., Gong Y., Eng S., Brennan C.W., et al. Genomic dissection of the epidermal growth factor receptor (EGFR)/PI3K pathway reveals frequent deletion of the EGFR phosphatase PTPRS in head and neck cancers. Proc. Natl. Acad. Sci. U. S. A. 2011, 108:19024-19029.
56. Guichard C., Amaddeo G., Imbeaud S., Ladeiro Y., Pelletier L., Maad I.B., et al. Integrated analysis of somatic mutations and focal copy-number changes identifies key genes and pathways in hepatocellular carcinoma. Nat. Genet. 2012, 44:694-698.
57. Hirsch D., Kemmerling R., Davis S., Camps J., Meltzer P.S., Ried T., et al. Chromothripsis and focal copy number alterations determine poor outcome in malignant melanoma. Cancer Res. 2013, 73:1454-1460.
58. Müller F.L., Colla S., Aquilanti E., Manzo V.E., Genovese G., Lee J., et al. Passenger deletions generate therapeutic vulnerabilities in cancer. Nature 2012, 488:337-342.
59. Yang L., Luquette L.J., Gehlenborg N., Xi R., Haseley P.S., Hsieh C.H., et al. Diverse mechanisms of somatic structural variations in human cancer genomes. Cell 2013, 153:919-929.
60. Bradley W.E., Raelson J.V., Dubois D.Y., Godin E., Fournier H., Privé C., et al. Hotspots of large rare deletions in the human genome. PLoS ONE 2010, 5:e9401.
61. Korbel J.O., Campbell P.J. Criteria for inference of chromothripsis in cancer genomes. Cell 2013, 152:1226-1236.
62. Stephens P.J., Tarpey P.S., Davies H., Van Loo P., Greenman C., Wedge D.C., et al. The landscape of cancer genes and mutational processes in breast cancer. Nature 2012, 486:400-404.
63. Baca S.C., Prandi D., Lawrence M.S., Mosquera J.M., Romanel A., Drier Y., et al. Punctuated evolution of prostate cancer genomes. Cell 2013, 153:666-677.
64. Smith D.I., Zhu Y., McAvoy S., Kuhn R. Common fragile sites, extremely large genes, neural development and cancer. Cancer Lett. 2006, 232:48-57.
65. Lawrence M.S., Stojanov P., Mermel C.H., Robinson J.T., Garraway L.A., Golub T.R., et al. Discovery and saturation analysis of cancer genes across 21 tumour types. Nature 2015, 505:495-501.